Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-31 Purchase | 2022-04-04 4:05 pm | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 6,400 | $1.53 | $9,792 | 113,237 (Direct) | View |
| 2022-03-28 Purchase | 2022-03-29 4:15 pm | Lineage Cell Therapeutics Inc. | LCTX | Amin Dipti Director | 35,000 | $1.63 | $57,050 | 35,000 (Direct) | View |
| 2022-03-25 Purchase | 2022-03-28 7:22 pm | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 5,250 | $1.38 | $7,245 | 81,280 (Direct) | View |
| 2022-03-23 Purchase | 2022-03-25 5:56 pm | Lineage Cell Therapeutics Inc. | LCTX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C Director 10% Owner | 930,106 | $1.4167 | $1,317,667 | 69,958,598 (Indirect Direct) | View |
| 2022-03-24 Purchase | 2022-03-25 4:15 pm | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 7,000 | $1.4 | $9,800 | 258,555 (Direct) | View |
| 2021-12-28 Sale | 2021-12-30 5:20 pm | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP Clinical & Medical Affairs | 539,283 | $2.4502 | $1,321,329 | 551,862 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-14 Option Award | 2022-11-16 4:17 pm | N/A 2032-11-14 | Lineage Cell Therapeutics Inc. | LCTX | Howe Jill Ann Chief Financial Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2022-07-07 Ownership | 2022-07-08 6:25 pm | N/A 2029-09-01 | Lineage Cell Therapeutics Inc. | LCTX | Hernandez Alexandra Sr Director Finance/Controller | 0 | $0 | 219,892 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:16 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Russell Angus C. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Jayasuriya Anula Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BAILEY DON M Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BRADSHER NEAL C Director 10% Owner | 50,000 | $0 | 229,440 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Amin Dipti Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-06-30 5:57 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 5,343 | $1.58 | 107,894 (Direct) | View |
| 2022-06-30 Exercise | 2022-06-30 5:57 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 15,450 | $0 | 107,894 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 4:05 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 5,343 | $1.54 | 113,237 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 4:05 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 15,450 | $0 | 113,237 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-11 8:45 pm | N/A 2032-03-10 | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 1,550,000 | $0 | 1,550,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-11 8:44 pm | N/A 2032-03-10 | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary | 650,000 | $0 | 650,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-11 8:43 pm | N/A 2032-03-10 | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP Clinical & Medical Affairs | 450,000 | $0 | 450,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-11 8:42 pm | N/A 2032-03-10 | Lineage Cell Therapeutics Inc. | LCTX | Cook Kevin Leon Chief Financial Officer | 650,000 | $0 | 650,000 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 7:45 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary | 24,303 | $0 | 24,303 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 7:42 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP Clinical & Medical Affairs | 52,081 | $0 | 52,081 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 7:40 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Cook Kevin Leon Chief Financial Officer | 13,888 | $0 | 13,888 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 7:38 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 124,997 | $0 | 124,997 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-11 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 14,700 | $0 | 6,874,242 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-11 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 0 | $0 | 6,874,242 (Indirect) | View |
| 2021-12-31 Exercise | 2022-01-03 4:25 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 15,450 | $0 | 106,930 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-03 4:25 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 5,343 | $2.45 | 106,930 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:20 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP Clinical & Medical Affairs | 236,899 | $2.11 | 551,862 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:20 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP Clinical & Medical Affairs | 510,838 | $0 | 551,862 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:20 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP Clinical & Medical Affairs | 194,250 | $0.6919 | 551,862 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:20 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP Clinical & Medical Affairs | 79,689 | $1.14 | 551,862 (Direct) | View |
| 2021-09-30 Exercise | 2021-10-12 4:27 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 15,450 | $0 | 112,273 (Direct) | View |
| 2021-09-30 Tax Withholding | 2021-10-12 4:27 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 5,343 | $2.52 | 112,273 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-02 4:20 pm | N/A 2031-09-01 | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary | 695,000 | $0 | 695,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:32 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BAILEY DON M Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:29 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:26 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Amin Dipti Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:24 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Russell Angus C. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:24 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BRADSHER NEAL C Director 10% Owner | 50,000 | $0 | 204,160 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:21 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:19 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:17 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Jayasuriya Anula Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-06-21 Option Award | 2021-07-01 4:21 pm | N/A 2031-06-20 | Lineage Cell Therapeutics Inc. | LCTX | Cook Kevin Leon Chief Financial Officer | 750,000 | $0 | 750,000 (Direct) | View |